<DOC>
	<DOCNO>NCT02021825</DOCNO>
	<brief_summary>The treatment protocol consist 12 mg/m2 MITO intravenous infusion every 3 month 2 year . Dosage adjust accord side effect . Neurological assessment include determination Expanded Disability Status Scale ( EDSS ) score ophthalmologic evaluation perform every 3 month relapse . Flow cytometric analysis , brain spinal cord MRI perform baseline , 6 , 12 , 18 , 24 month .</brief_summary>
	<brief_title>Efficacy Safety Mitoxantrone Patients With Refractory Neuromyelitis Optica Spectrum Disorders</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Neuromyelitis Optica</mesh_term>
	<mesh_term>Mitoxantrone</mesh_term>
	<criteria>Recurrent longitudinal myelitis ( &gt; 3 segment spinal cord involvement MRI ) without recurrent ON ( unilateral bilateral ) normal brain MRI positive serological NMO IgG antibody . Recurrent longitudinal myelitis ( &gt; 3 segment spinal cord involvement MRI ) without spatially limited brain lesion positive serological NMO IgG antibody . NMO , fulfil Wingerchuk 2006 Criteria NMO . Patient present least 2 relapse 12 month precede start mitoxantrone therapy , despite immunotherapy use corticosteroid , interferon beta , azathioprine , cyclophosphamide , Cyclosporin A , Mycophenolate Mofetil combination drug Extended Disability Status Score 38 . Normal range whitebloodcell count ( 4×109/L ) , neutrophil count ( 2×109/L ) , platelet count ( 100×109/L ) . Cardiac risk factor ( e.g history congestive heart failure leave ventricular ejection fraction ( LVEF ) &lt; 50 % Systemic diseases lupus , Sjogren 's syndrome , antiphospholipid antibody syndrome , sarcoidosis , rheumatoid arthritis , vitamin B12 deficiency Previous treatment mitoxantrone anthracyclines Pregnant planning pregnant Patients severe liver disorder ( WHO grade 4 )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>mitoxantrone</keyword>
	<keyword>neuromyelitis optica</keyword>
	<keyword>relapse</keyword>
</DOC>